Modified ablation for atrial fibrillation patients with normal heart tissue
Part of Heart & circulation clinical trials.
This study tests a new ablation method for people with atrial fibrillation who have not had a prior episode and whose heart tissue shows no low-voltage areas but has a transition zone during mapping. It aims to see if targeting this area improves outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have atrial fibrillation and are scheduled for an ablation procedure.
- You have not had atrial fibrillation before.
- Your heart's electrical mapping shows no low-voltage areas.
- Your heart's electrical mapping shows a transition zone.
- You are able to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a specific approach to catheter ablation for people with persistent atrial fibrillation. It aims to improve how abnormal heart tissue is targeted to help restore a normal rhythm.
This study compares two types of ablation (a procedure that uses energy to fix irregular heartbeats) for people with persistent atrial fibrillation. It tests whether adding extra treatment to the back of the heart's left upper chamber helps improve outcomes compared to standard treatment alone.
This study tests a new type of ablation (pulsed field ablation) for people with atrial fibrillation who haven't gotten enough relief from medication alone. It aims to see if isolating the superior vena cava along with the pulmonary veins is safe and effective.
This trial is testing a new way to measure electrical signals in the heart during a procedure called pulmonary vein isolation, which treats atrial fibrillation (a type of irregular heartbeat). It is for people who are having this procedure for the first time and whose heart is in a normal rhythm at the time of treatment.
This trial tests whether using a special heart-mapping device during ablation (a procedure to fix irregular heartbeats) can improve outcomes for people with persistent atrial fibrillation and an enlarged left heart chamber.
This trial is testing a new way to treat atrial fibrillation by using a catheter to target the specific areas in the heart that trigger the irregular heartbeat. If you have persistent atrial fibrillation and haven't had prior catheter ablation, you may be eligible to join.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.